Related Experiment Video
Updated: Jun 21, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species
Ahmed Lazrak1, Karen E Iles, Gang Liu
1Department of Anesthesiology, Schools of Medicine and Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Abstract:
The mechanisms by which replicating influenza viruses decrease the expression and function of amiloride-sensitive epithelial sodium channels (ENaCs) have not been elucidated. We show that expression of M2, a transmembrane influenza protein, decreases ENaC membrane levels and amiloride-sensitive currents in both Xenopus oocytes, injected with human alpha-, beta-, and gamma-ENaCs, and human airway cells (H441 and A549), which express native ENaCs. Deletion of a 10-aa region within the M2 C terminus prevented 70% of this effect. The M2 ENaC down-regulation occurred at normal pH and was prevented by MG-132, a proteasome and lysosome inhibitor. M2 had no effect on Liddle ENaCs, which have decreased affinity for Nedd4-2. H441 and A549 cells transfected with M2 showed higher levels of reactive oxygen species, as shown by the activation of redox-sensitive dyes. Pretreatment with glutathione ester, which increases intracellular reduced thiol concentrations, or protein kinase C (PKC) inhibitors prevented the deleterious effects of M2 on ENaCs. The data suggest that M2 protein increases steady-state concentrations of reactive oxygen intermediates that simulate PKC and decrease ENaCs by enhancing endocytosis and its subsequent destruction by the proteasome. These novel findings suggest a mechanism for the influenza-induced rhinorrhea and life-threatening alveolar edema in humans.
Insights
Influenza M2 protein reduces epithelial sodium channel (ENaC) function by increasing oxidative stress and proteasomal degradation. This mechanism explains influenza-induced fluid imbalance in airways and lungs.
Area of Science:
- Cell Biology
- Virology
- Respiratory Physiology
Background:
- Influenza viruses disrupt epithelial sodium channel (ENaC) function, but the underlying mechanisms remain unclear.
- ENaCs are crucial for regulating airway surface liquid and lung fluid balance.
Purpose of the Study:
- To elucidate the mechanism by which influenza M2 protein down-regulates ENaC expression and function.
- To investigate the role of oxidative stress and cellular degradation pathways in M2-mediated ENaC dysfunction.
Main Methods:
- Expression of M2 protein in Xenopus oocytes and human airway cell lines (H441, A549).
- Measurement of ENaC membrane levels and amiloride-sensitive currents.
- Assessment of reactive oxygen species (ROS) production and effects of antioxidants and kinase inhibitors.
- Investigation using proteasome/lysosome inhibitors (MG-132) and analysis of Liddle ENaCs.
Main Results:
- Influenza M2 protein expression decreased ENaC membrane levels and amiloride-sensitive currents in both oocytes and airway cells.
- A specific M2 C-terminal region was critical for this down-regulation.
- M2-induced ENaC reduction was linked to increased reactive oxygen species (ROS) and was prevented by antioxidants and PKC inhibitors.
- Inhibition of proteasome and lysosome pathways blocked M2's effect, suggesting enhanced degradation.
Conclusions:
- Influenza M2 protein triggers oxidative stress, activating protein kinase C (PKC) pathways.
- This leads to enhanced endocytosis and proteasomal degradation of ENaCs, reducing their function.
- This mechanism contributes to influenza-associated airway and lung fluid dysregulation, potentially causing edema.
More Related Videos
11:20Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Inhibitors Of Virion Release
Influenza
Leaky Scanning
Inhibitors of Viral Protein Synthesis
Respiratory Syncytial Virus Disease
Inhibitors of Virion Maturation and Assembly